Nancy Lynn Snyderman MD - 26 Jun 2023 Form 4 Insider Report for Axonics, Inc.

Role
Director
Signature
/s/ Dan Dearen, as Attorney-in-Fact for Nancy Lynn Snyderman, M.D.
Issuer symbol
N/A
Transactions as of
26 Jun 2023
Net transactions value
$0
Form type
4
Filing time
28 Jun 2023, 20:21:41 UTC
Previous filing
22 Aug 2022
Next filing
30 Jun 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXNX Common Stock Award $0 +3,000 +18% $0.000000 19,944 26 Jun 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.